{"id":"https://openalex.org/W1685907256","doi":null,"title":"THE NON-STEROIDAL ANTI- INFLAMMATORY DRUGS-MYOCARDIAL INFARCTION ASSOCIATION: AN INVESTIGATION OF KENTUCKY MEDICAID PRESCRIPTION CLAIMS","display_name":"THE NON-STEROIDAL ANTI- INFLAMMATORY DRUGS-MYOCARDIAL INFARCTION ASSOCIATION: AN INVESTIGATION OF KENTUCKY MEDICAID PRESCRIPTION CLAIMS","alternate_titles":[],"publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W1685907256","mag":"1685907256"},"language":"en","primary_location":{"id":"pmh:oai:uknowledge.uky.edu:epb_etds-1007","doi":null,"is_oa":true,"landing_page_url":"https://uknowledge.uky.edu/epb_etds/8","pdf_url":"https://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1007&context=epb_etds","source":{"id":"https://openalex.org/S4306402623","display_name":"UKnowledge (University of Kentucky)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I143302722","host_organization_name":"University of Kentucky","host_organization_lineage":["https://openalex.org/I143302722"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Theses and Dissertations--Epidemiology and Biostatistics","raw_type":"text"},"parent_works":[],"lineage":["https://openalex.org/W1685907256"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1007&context=epb_etds","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Leonard A. Gordon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Leonard A. Gordon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.9200000166893005},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.9629999995231628},{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.8600000143051147},{"id":"https://openalex.org/keywords/cox-1-inhibitors","display_name":"COX-1 inhibitors","score":0.7360000014305115},{"id":"https://openalex.org/keywords/meloxicam","display_name":"meloxicam","score":0.949999988079071},{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/naproxen","display_name":"naproxen","score":1.0},{"id":"https://openalex.org/keywords/young-adults","display_name":"young adults","score":0.5920000076293945},{"id":"https://openalex.org/keywords/medicaid","display_name":"Medicaid","score":0.4699999988079071},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.7200000286102295},{"id":"https://openalex.org/keywords/prescription-claims","display_name":"prescription claims","score":0.5929999947547913},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5040000081062317},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5479999780654907},{"id":"https://openalex.org/keywords/cardiovascular-disease-burden","display_name":"cardiovascular disease burden","score":0.41600000858306885}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.914223849773407},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.6958608627319336},{"id":"https://openalex.org/C2776534028","wikidata":"https://www.wikidata.org/wiki/Q1141363","display_name":"Medicaid","level":3,"score":0.5838689804077148},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.574560284614563},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.5309364795684814},{"id":"https://openalex.org/C2779751750","wikidata":"https://www.wikidata.org/wiki/Q414028","display_name":"Meloxicam","level":2,"score":0.5146180391311646},{"id":"https://openalex.org/C2778582115","wikidata":"https://www.wikidata.org/wiki/Q411412","display_name":"Rofecoxib","level":4,"score":0.46103882789611816},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4352276921272278},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4154529571533203},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.4136078357696533},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.19035279750823975},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.1422223448753357},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.06735575199127197},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:uknowledge.uky.edu:epb_etds-1007","doi":null,"is_oa":true,"landing_page_url":"https://uknowledge.uky.edu/epb_etds/8","pdf_url":"https://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1007&context=epb_etds","source":{"id":"https://openalex.org/S4306402623","display_name":"UKnowledge (University of Kentucky)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I143302722","host_organization_name":"University of Kentucky","host_organization_lineage":["https://openalex.org/I143302722"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Theses and Dissertations--Epidemiology and Biostatistics","raw_type":"text"},{"id":"mag:1685907256","doi":null,"is_oa":false,"landing_page_url":"https://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1007&context=epb_etds","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:uknowledge.uky.edu:epb_etds-1007","doi":null,"is_oa":true,"landing_page_url":"https://uknowledge.uky.edu/epb_etds/8","pdf_url":"https://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1007&context=epb_etds","source":{"id":"https://openalex.org/S4306402623","display_name":"UKnowledge (University of Kentucky)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I143302722","host_organization_name":"University of Kentucky","host_organization_lineage":["https://openalex.org/I143302722"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Theses and Dissertations--Epidemiology and Biostatistics","raw_type":"text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1685907256.pdf","grobid_xml":"https://content.openalex.org/works/W1685907256.grobid-xml"},"referenced_works_count":75,"referenced_works":["https://openalex.org/W123303041","https://openalex.org/W201364903","https://openalex.org/W1491811518","https://openalex.org/W1579760457","https://openalex.org/W1761271291","https://openalex.org/W1922681024","https://openalex.org/W1964134138","https://openalex.org/W1965108173","https://openalex.org/W1965992514","https://openalex.org/W1969798546","https://openalex.org/W1972821304","https://openalex.org/W1977473142","https://openalex.org/W1980271665","https://openalex.org/W1986077106","https://openalex.org/W1992416338","https://openalex.org/W1993961357","https://openalex.org/W1995355693","https://openalex.org/W1995528018","https://openalex.org/W1997196107","https://openalex.org/W1998443206","https://openalex.org/W2002178040","https://openalex.org/W2008225822","https://openalex.org/W2010818945","https://openalex.org/W2012920835","https://openalex.org/W2014184499","https://openalex.org/W2015890865","https://openalex.org/W2016592209","https://openalex.org/W2020036206","https://openalex.org/W2022603919","https://openalex.org/W2024233889","https://openalex.org/W2031129849","https://openalex.org/W2036190325","https://openalex.org/W2038932922","https://openalex.org/W2039726110","https://openalex.org/W2043666180","https://openalex.org/W2057685090","https://openalex.org/W2060235225","https://openalex.org/W2061326496","https://openalex.org/W2063252400","https://openalex.org/W2067621583","https://openalex.org/W2070469088","https://openalex.org/W2076263459","https://openalex.org/W2082672105","https://openalex.org/W2085522500","https://openalex.org/W2087771673","https://openalex.org/W2089597863","https://openalex.org/W2100631748","https://openalex.org/W2107079398","https://openalex.org/W2114949308","https://openalex.org/W2117784691","https://openalex.org/W2117935315","https://openalex.org/W2119800046","https://openalex.org/W2134634779","https://openalex.org/W2135393211","https://openalex.org/W2136555831","https://openalex.org/W2139776244","https://openalex.org/W2143995569","https://openalex.org/W2145761072","https://openalex.org/W2145816148","https://openalex.org/W2145839235","https://openalex.org/W2148359829","https://openalex.org/W2152347976","https://openalex.org/W2156958131","https://openalex.org/W2158131645","https://openalex.org/W2158968701","https://openalex.org/W2159767143","https://openalex.org/W2163756514","https://openalex.org/W2164595809","https://openalex.org/W2168733098","https://openalex.org/W2172253009","https://openalex.org/W2184674093","https://openalex.org/W2291834160","https://openalex.org/W2330496155","https://openalex.org/W2741466733","https://openalex.org/W4245021956"],"related_works":["https://openalex.org/W2763212368","https://openalex.org/W1983393465","https://openalex.org/W1970351453","https://openalex.org/W2058112155","https://openalex.org/W2016592209","https://openalex.org/W2505430032","https://openalex.org/W2103958123","https://openalex.org/W2275099880","https://openalex.org/W2145839235","https://openalex.org/W2082672105"],"abstract_inverted_index":{"Non-steroidal":[0],"anti-inflammatory":[1],"drugs":[2],"(NSAIDs)":[3],"are":[4,13,24,70],"among":[5],"the":[6,28,60,63,74,81,89,97,105,118,147,150,162,182],"most":[7],"widely":[8],"used":[9,26],"medications":[10],"globally.":[11],"There":[12],"generally":[14],"two":[15],"types:":[16],"selective":[17],"(COX-2)":[18],"and":[19,53,79,122,178,188,205,214,237,274,283,301,328,333],"traditional":[20],"NSAIDs":[21,52,121,332],"(COX-1).":[22],"They":[23,32],"primarily":[25],"for":[27,175,252,262,296,308],"treatment":[29],"of":[30,55,62,76,91,96,100,104,112,137,149,185,228,317,331,341],"pain.":[31],"gained":[33],"attention":[34],"after":[35],"a":[36,125,133,166,171,220,292,304],"study":[37,196,224,314],"about":[38],"their":[39,43],"basic":[40],"mechanisms":[41],"highlighted":[42],"toxicity.":[44],"Several":[45],"studies":[46,69],"have":[47],"reported":[48],"an":[49,248],"association":[50,107,119],"between":[51,120,339],"risk":[54,184,251,258,295,307],"myocardial":[56],"infarction":[57],"(MI).":[58],"However,":[59,256],"direction":[61,75],"relationship":[64,78,164],"is":[65,108],"not":[66],"conclusive.":[67],"Further":[68],"needed":[71],"to":[72,88,116,145,156,160,180,191,232,244,267,286],"ascertain":[73],"this":[77,113,218,257],"evaluate":[80,161],"present":[82],"situation":[83],"with":[84,132,154,165],"available":[85],"drugs.":[86],"Due":[87],"seriousness":[90],"cardiovascular":[92,176],"diseases":[93],"as":[94],"one":[95],"leading":[98],"cause":[99],"death,":[101],"continuous":[102,321,327],"monitoring":[103],"NSAIDs-MI":[106],"needed.":[109],"The":[110,139,209,239],"purpose":[111],"dissertation":[114],"was":[115,197,225,259],"investigate":[117,181],"MI":[123,183,229,253,297,309],"in":[124,170,319],"younger":[126],"(30-64":[127],"years)":[128],"Kentucky":[129,151],"Medicaid":[130,152],"population":[131,153,174],"12":[134,167],"year":[135,168,276],"window":[136],"data.":[138],"three":[140],"specific":[141],"aims":[142],"were:":[143],"(1)":[144],"understand":[146],"characteristics":[148],"respect":[155],"NSAID":[157],"use:":[158],"(2)":[159],"NSAID-MI":[163],"follow-up":[169],"young":[172],"heavily-burdened":[173],"diseases:":[177],"(3)":[179],"meloxicam,":[186],"celecoxib":[187,282,302],"naproxen":[189,284],"compared":[190,266,285],"no":[192,287],"exposure.":[193],"A":[194],"retrospective":[195],"conducted":[198],"employing":[199],"data":[200,210],"from":[201],"January":[202],"1st":[203],"2000":[204],"December":[206],"31st":[207],"2012.":[208],"comprised":[211],"demographic,":[212],"prescription":[213],"medical":[215],"files.":[216],"Within":[217],"cohort,":[219],"nested":[221],"case":[222],"control":[223],"conducted.":[226],"Cases":[227],"were":[230],"matched":[231],"four":[233],"controls":[234],"on":[235],"race":[236],"gender.":[238],"results":[240],"suggested":[241],"that":[242],"exposure":[243,288],"COX":[245],"2":[246],"presented":[247,291,303],"increased":[249,261,306],"adjusted":[250],"(1.138(0.983,":[254],"1.318)).":[255],"significantly":[260,305],"COX-2":[263],"only":[264,269],"users":[265,270,330],"COX-1":[268],"(1.221":[271],"(1.03,":[272],"1.485))":[273],"30-40":[275],"olds":[277],"(1.600":[278],"(1.082,":[279],"2.367)).":[280],"Meloxicam,":[281],"showed":[289],"meloxicam":[290],"non-significant":[293],"different":[294],"(1.26":[298],"(0.98,":[299],"1.63))":[300],"(1.52":[310],"(1.26,":[311],"1.82)).":[312],"This":[313],"considered":[315,335],"pattern":[316],"use":[318],"determining":[320],"usage":[322],"by":[323],"looking":[324],"at":[325],"both":[326],"sporadic":[329],"also":[334],"patient":[336],"switching":[337],"patterns":[338],"classes":[340],"NSAIDs.":[342]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1685907256","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
